These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1375798)

  • 41. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
    Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
    Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histopathology of bone marrow in human chronic leukemias.
    Georgii A
    Haematol Blood Transfus; 1979; 23():59-70. PubMed ID: 296116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes of nucleolar organizer regions in granulopoietic precursors during the course of chronic myeloid leukemia.
    Gilberti MF; Metze K; Lorand-Metze I
    Ann Hematol; 1995 Dec; 71(6):275-9. PubMed ID: 8534758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histomorphometric study of megakaryocytes in bone marrow in selected myeloproliferative and lymphoproliferative diseases.
    Lemancewicz D; Dziecioł J; Kłoczko J; Litwiejko-Pietryńczak E; Bogusłowicz W
    Folia Morphol (Warsz); 2003 Feb; 62(1):51-6. PubMed ID: 12769178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
    Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
    Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined immunocytochemistry and nucleolar organizer region staining: some technical aspects.
    McMeekin W; Kennedy A; McNicol AM
    Med Lab Sci; 1989 Jan; 46(1):11-5. PubMed ID: 2476643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies.
    Georgii A; Buhr T; Buesche G; Kreft A; Choritz H
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():15-29. PubMed ID: 8951769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond.
    Michiels JJ
    Hematology; 2005; 10 Suppl 1():215-23. PubMed ID: 16188676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell kinetic analysis of interleukin-2 receptor-tested chronic lymphocytic leukemia using the AgNOR silver stain.
    Mourad WA; Pugh WC; Huh YO; Keating MJ
    Am J Clin Pathol; 1994 Mar; 101(3):300-4. PubMed ID: 8135185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients.
    Pich A; Chiusa L; Audisio E; Marmont F
    J Clin Oncol; 1998 Apr; 16(4):1512-8. PubMed ID: 9552060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nucleolar organizer regions in the fine needle aspirates of lung tumours.
    Ascoli V; Barsotti P; Facciolo F; Nardi F; Marinozzi V
    Cytopathology; 1990; 1(5):277-86. PubMed ID: 1714309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Various activities of the nucleolus organizer region in normal and leukemic bone marrow cells: semiquantitative data and computer- assisted image analysis by silver staining].
    Arden KC; Pathak S
    Gematol Transfuziol; 1990 Nov; 35(11):4-11. PubMed ID: 1704334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emperipolesis--a peculiar feature of megakaryocytes as evaluated in chronic myeloproliferative diseases by morphometry and ultrastructure.
    Thiele J; Krech R; Choritz H; Georgii A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 46(3):253-63. PubMed ID: 6148804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies.
    Pich A; Chiusa L; Marmont F; Cappello N; Navone R
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):143-7. PubMed ID: 1514245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic myeloproliferative disorders in bone marrow biopsies.
    Georgii A; Vykoupil KF; Buhr T; Choritz H; Döhler U; Kaloutsi V; Werner M
    Pathol Res Pract; 1990 Feb; 186(1):3-27. PubMed ID: 2179909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinctive AgNOR patterns of myeloid and lymphoid blasts in acute leukemia.
    Shome DK; Khurana N
    Am J Hematol; 1999 Jun; 61(2):149-52. PubMed ID: 10367797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proliferative activity in normal salivary gland and pleomorphic adenoma. A study by argyrophilic nucleolar organizer region (AgNOR) staining.
    Fujita S; Takahashi H; Okabe H
    Acta Pathol Jpn; 1992 Aug; 42(8):573-8. PubMed ID: 1280396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.